PTX:ASX
Prescient Therapeutics Ltd
A$0.067
arrow_downward
-1.47%(-0.0010) 1D
Aug 28, 4:10:16 PM GMT+10 · AUD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTX...
Open
A$0.07
High
A$0.07
Low
A$0.07
Mkt. cap
68.44M
Avg. vol.
1.09M
Volume
681.43K
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.05B
No. of employees
3
Open
A$0.07
High
A$0.07
Low
A$0.07
Mkt. cap
68.44M
Avg. vol.
1.09M
Volume
681.43K
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.05B
No. of employees
3
News stories
From web sources and news partners
Kalkine Media
·
3 days ago
Prescient Therapeutics Announces $7 Million Share Purchase Plan at $0.065 Per Share
Profile
Prescient Therapeutics Ltd is a clinical stage oncology company. The company is focused on the development of a universal CAR-T platform, enhanced CAR-T cell manufacturing & function and on two small molecule drug targeted therapies. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
FoundedMay 22, 1986
Headquarters-
SectorBiotechnology
Websiteptxtherapeutics.com
AI content may include mistakes. Learn more